Defensive coping facilitates higher blood pressure and early sub-clinical structural vascular disease via alterations in heart rate variability: The SABPA study

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 391-397

  Malan, L ^a   Hamer, M ^a,b   Schlaich, M P ^c   Lambert, G ^c   Ziemssen, T ^d   Reimann, M ^d   Frasure Smith, N ^e   Amirkhan, J H ^f   Schutte, R ^a   van Rooyen, J M ^a   Mels, C M ^a   Fourie, C M T ^a   Uys, A S ^a   Malan, N T ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e MCGILL UNIVERSITY   (Canada)

^f CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Autonomic function; Coping; Ethnicity; Sub clinical vascular disease

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; HIGH SENSITIVITY C REACTIVE PROTEIN; THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; AFRICA; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DEFENSIVE COPING; DIET RESTRICTION; ETHNICITY; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; VASCULAR DISEASE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTHROPOMETRY; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; STRESS, PSYCHOLOGICAL; URBAN POPULATION; VASCULAR DISEASES;

EID: 84875054268     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.001     Document Type: Article

References (31)

1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996, 17:354-381.
2. Malik M., Bigger J.T., Camm A.J., et al. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996, 17:354-381.
3. Thayer J.F., åhs F., Fredrikson M., Sollers J.J., Wagner T.D. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev 2012, 36:747-756.
4. Greenland P., Alpert J.S., Beller G.A., et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010, 56:e50-103.
5. DeGiorgio C.M., Faan M.D., Miller P., et al. RMSSD, a measure of heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav 2010, 19(1):78-81.
6. Pizzi C., Manzoli L., Mancini S., Costa G.M. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008, 29:1110-1117.
7. Hamer M., Malan L., Malan N.T., et al. Objectively assessed health behaviors and sub-clinical atherosclerosis in black and white Africans: the SABPA study. Atherosclerosis 2011, 215:237-242.
8. Malan L., Hamer M., Schlaich M.P., et al. Facilitated defensive coping, silent ischemia and ECG left ventricular hypertrophy: the SABPA Study. J Hypertens 2012, 30(3):543-550.
9. Anderson N.B., McNeilly M. Autonomic reactivity and hypertension in blacks: toward a contextual model. Pathophysiology of hypertension in blacks 1993, 104-125. Oxford University Press, New York. J.C.S. Fray, J.G. Douglas (Eds.).
10. Hinderliter A.L., Blumenthal J.A., Waugh R., Chilukuri M., Sherwood A. Ethnic differences in left ventricular structure: relations to hemodynamics and diurnal blood pressure variation. Am J Hypertens 2004, 17:43-49.
11. Malan L., Malan N.T., Wissing M.P., Seedat Y.K. Coping with urbanization: a cardiometabolic risk? the THUSA study. Biol Psychol 2008, 79:323-328.
12. Jarvis M.J., Tunstall-Pedoe H., Feyerabend C., Vesey C., Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987, 77:1435-1438.
13. The merck MANUAL of diagnosis and therapy 2011, 3754. John Wiley & Sons, San Francisco. 19th ed. R.S. Porter (Ed.).
14. Kohara K., Nishida W., Maguchi M., Hiwida K. Autonomic nervous function in non-dipper essential hypertensive participants: evaluation by power spectral analysis of heart rate variability. Hypertension 1995, 26:808.
15. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement. J Am Soc Echocardiogr 2008, 93-111.
16. Liang Y.L., Teede H., Kotsoupoulos D., et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial samples size. Clin Sci 1998, 95:669-679.
17. Amirkhan J.H. A factor analytically derived measure of coping: the coping strategy indicator. J Pers Soc Psych 1990, 59:1066-1074.
18. Opie L.H. Heart physiology - from cell to circulation 2004, Lippincott Williams & Wilkins, USA, p. 421. 4th ed.
19. Grassi G., Arenare F., Quarti-Trevano F., et al. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog Cardiovasc Dis 2009, 52:31-37.
20. Harris K.F., Matthews K.A. Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med 2004, 66:153-164.
21. Van Lill A.S., Malan L., van Rooyen J.M., et al. Baroreceptor sensitivity and left ventricular hypertrophy in urban South African men: the SABPA study. Blood Press 2011, 20:355-361.
22. Yeung A.C., Ganz P., Selwyn A.P. Interactions between mental stress and coronary endothelial dysfunction. Homeostasis 1993, 34:244-251.
23. Hamer M., Malan L. Psychophysiological risk markers of cardiovascular disease. Neuro Biobehav Rev 2010, vol. 35:76-83. Special ed.
24. LeDoux J.E. Evolution of human emotion: a view through fear. Prog Brain Res 2012, 195:431-442.
25. Folkow B., Rubinstein E.H. Cardiovascular effects of acute and chronic stimulation of the hypothalamic defense area in the rat. Acta Physiol Scand 1966, 68:48-57.
26. Ryff C.D., Singer N. From social structure to biology. Handbook of positive psychology 2007, 541-555. Oxford University Press. C.R. Snyder, S.J. Lopez (Eds.).
27. Bourdillon M.F.C. Christianity and wealth in rural communities in Zimbabwe. Zambezia 1983, XI(i):38-53.
28. Van de Borne P., Mark A., Montano N., et al. Effects of alcohol on sympathetic activity, heamodynamics and chemoreflex sensitivity. Hypertension 1997, 29:1278-1283.
29. Sjöberg L., Samsonowitz V. Coping strategies and relapse in alcohol abuse. Drug Alcohol Depend 1985, 15:283-301.
30. Hermans E.J., Putman P., Baas J.M., et al. Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology 2007, 1052-1061.
31. Ramirez-Villegas J.F., Lam-Espinosa E., Ramirez-Moreno D.F., et al. Heart rate variability dynamics for the prognosis of cardiovascular risk. PLoS ONE 2011, 6(2):e17060.